Eli Lilly Corp. buy UBS Group AG
Start price
18.03.26
/
50%
€795.20
Target price
18.03.27
-
Performance (%)
-2.57%
Price
14:57
€774.80
Summary
This prediction is currently active. With a performance of -2.57%, the BUY prediction for Eli Lilly Corp. by UBS_Group_AG is down slightly. This prediction currently runs until 18.03.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Eli Lilly Corp. | -6.096% |
| iShares Core DAX® | 0,44 % |
| iShares Nasdaq 100 | 3,82 % |
| iShares Nikkei 225® | 1,15 % |
| iShares S&P 500 | 2,37 % |
Comments by UBS_Group_AG for this prediction
In the thread Eli Lilly Corp. diskutieren
Eli Lilly and Company (LLY) had its "buy" rating reaffirmed by UBS Group AG.
Ratings data for LLY provided by MarketBeat
Stopped prediction by UBS_Group_AG for Eli Lilly Corp.
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€557.00
20.10.23
20.10.23
€670.67
20.10.24
20.10.24
51.40%
21.10.24
21.10.24
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€397.00
24.05.23
24.05.23
€462.89
24.05.24
24.05.24
88.34%
25.05.24
25.05.24